A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL
Clinical trial NCT04532268 · RECRUITING
Trial details
- NCT number
- NCT04532268
- Sponsor
- Zhejiang University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-23
- Primary completion
- 2023-08-23
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.